Stock listing
ALKS Stock Price, News, Filings & Events — Alkermes Plc
Selected listing: ALKS · NASDAQ · USD · US
This page tracks Alkermes Plc's ALKS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALKS:NASDAQ. ALKS:NASDAQ is the stock-level entry point for investors researching Alkermes Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alkermes Plc (Ticker: ALKS) is a public company based in America, with a market capitalization of approximately $8.82 billion. The company focuses on developing innovative medicines for patients with serious mental health conditions and addiction. Alkermes is committed to improving patient outcomes through its research and development efforts.
- Ticker
- ALKS:NASDAQ
- Asset type
- Stock
- Market cap
- $8.11B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Alkermes Plc ALKS:NASDAQ stock context
This page tracks Alkermes Plc's ALKS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALKS:NASDAQ. ALKS:NASDAQ is the stock-level entry point for investors researching Alkermes Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Alkermes Plc (Ticker: ALKS) is a public company based in America, with a market capitalization of approximately $8.82 billion. The company focuses on developing innovative medicines for patients with serious mental health conditions and addiction. Alkermes is committed to improving patient outcomes through its research and development efforts.
Latest news from Alkermes Plc
The Lancet Neurology Publishes Data From Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 1
August 24, 2026
Alkermes plc Reports Second Quarter 2026 Financial Results
July 28, 2026
Alkermes to Report Second Quarter Financial Results on July 28, 2026
July 14, 2026
Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extensio...
July 13, 2026
Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026
June 17, 2026
Alkermes Plc earnings calls
Alkermes plc (ALKS) Q2 2026 Earnings Call
July 28, 2026 · Replay with transcript and chapters
Alkermes plc (ALKS) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Alkermes plc (ALKS) Q4 2026 Earnings Call
February 25, 2026 · Replay with transcript and chapters
Alkermes plc (ALKS) Q3 2025 Earnings Call
October 28, 2025 · Replay with transcript and chapters
Alkermes plc (ALKS) Q2 2025 Earnings Call
July 29, 2025 · Replay with transcript and chapters
Alkermes plc (ALKS) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Alkermes Plc
Alkermes Plc investor report
Review AI stock analysis and investor report context for ALKS:NASDAQ.
Alkermes Plc company profile
View the public company page for Alkermes Plc on 6ix.
Alkermes Plc news
Read company news and market updates connected to Alkermes Plc.
Alkermes Plc investor events
Find investor webinars, events, and replay context for Alkermes Plc.
Alternate listings
A1JKVH:LSX
DE · EUR
Alternate listing for Alkermes Plc; the primary context on this page is ALKS:NASDAQ.
A1JKVH:LS
DE · EUR
Alternate listing for Alkermes Plc; the primary context on this page is ALKS:NASDAQ.
ALKS:BOATS
US · USD
Alternate listing for Alkermes Plc; the primary context on this page is ALKS:NASDAQ.
8AK:FWB
DE · EUR
Alternate listing for Alkermes Plc; the primary context on this page is ALKS:NASDAQ.
8AK:TRADEGATE
DE · EUR
Alternate listing for Alkermes Plc; the primary context on this page is ALKS:NASDAQ.
8AK:MUN
DE · EUR
Alternate listing for Alkermes Plc; the primary context on this page is ALKS:NASDAQ.
8AK:SWB
DE · EUR
Alternate listing for Alkermes Plc; the primary context on this page is ALKS:NASDAQ.